pilocarpine has been researched along with 1-(3-chlorophenyl)piperazine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brus, R; Fuller, RW; Kostrzewa, RM; Perry, KW | 1 |
| Kostrzewa, RM; Neely, D | 1 |
2 other study(ies) available for pilocarpine and 1-(3-chlorophenyl)piperazine
| Article | Year |
|---|---|
Supersensitization of the oral response to SKF 38393 in neonatal 6-hydroxydopamine-lesioned rats is eliminated by neonatal 5,7-dihydroxytryptamine treatment.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 5,7-Dihydroxytryptamine; Animals; Corpus Striatum; Female; Motor Activity; Mouth; Muscarinic Antagonists; Nerve Fibers; Oxidopamine; Pilocarpine; Piperazines; Pregnancy; Rats; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists | 1994 |
Enhanced pilocarpine-induced oral activity responses in neonatal 6-OHDA treated rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Animals, Newborn; Behavior, Animal; Brain Chemistry; Dose-Response Relationship, Drug; Female; Oxidopamine; Pilocarpine; Piperazines; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Cholinergic; Serotonin Receptor Agonists | 1993 |